NUTANIX INC - A (NTNX)

US67059N1081 - Common Stock

63.67  -0.78 (-1.21%)

After market: 63.6 -0.07 (-0.11%)

Fundamental Rating

3

Overall NTNX gets a fundamental rating of 3 out of 10. We evaluated NTNX against 280 industry peers in the Software industry. NTNX may be in some trouble as it scores bad on both profitability and health. NTNX is valied quite expensively at the moment, while it does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

In the past year NTNX was profitable.
NTNX had a positive operating cash flow in the past year.
In the past 5 years NTNX always reported negative net income.
In multiple years NTNX reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of NTNX (-3.62%) is comparable to the rest of the industry.
The Return On Invested Capital of NTNX (3.57%) is better than 71.33% of its industry peers.
Industry RankSector Rank
ROA -3.62%
ROE N/A
ROIC 3.57%
ROA(3y)-16.56%
ROA(5y)-28.9%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

NTNX has a Operating Margin of 1.95%. This is in the better half of the industry: NTNX outperforms 65.59% of its industry peers.
NTNX has a Gross Margin of 85.43%. This is amongst the best in the industry. NTNX outperforms 91.76% of its industry peers.
In the last couple of years the Gross Margin of NTNX has grown nicely.
Industry RankSector Rank
OM 1.95%
PM (TTM) N/A
GM 85.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.42%
GM growth 5Y2.41%

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NTNX is destroying value.
The number of shares outstanding for NTNX has been increased compared to 1 year ago.
The number of shares outstanding for NTNX has been increased compared to 5 years ago.
Compared to 1 year ago, NTNX has an improved debt to assets ratio.

2.2 Solvency

NTNX has an Altman-Z score of 1.77. This is a bad value and indicates that NTNX is not financially healthy and even has some risk of bankruptcy.
NTNX has a Altman-Z score (1.77) which is comparable to the rest of the industry.
NTNX has a debt to FCF ratio of 0.94. This is a very positive value and a sign of high solvency as it would only need 0.94 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 0.94, NTNX is doing good in the industry, outperforming 74.19% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 0.94
Altman-Z 1.77
ROIC/WACC0.3
WACC11.8%

2.3 Liquidity

NTNX has a Current Ratio of 1.25. This is a normal value and indicates that NTNX is financially healthy and should not expect problems in meeting its short term obligations.
NTNX has a worse Current ratio (1.25) than 63.80% of its industry peers.
A Quick Ratio of 1.25 indicates that NTNX should not have too much problems paying its short term obligations.
NTNX has a Quick ratio of 1.25. This is in the lower half of the industry: NTNX underperforms 63.44% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 1.25

6

3. Growth

3.1 Past

NTNX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.54%, which is quite impressive.
Looking at the last year, NTNX shows a quite strong growth in Revenue. The Revenue has grown by 14.86% in the last year.
The Revenue has been growing by 11.69% on average over the past years. This is quite good.
EPS 1Y (TTM)76.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.83%
Revenue 1Y (TTM)14.86%
Revenue growth 3Y15.51%
Revenue growth 5Y11.69%
Sales Q2Q%15.63%

3.2 Future

NTNX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.52% yearly.
NTNX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.39% yearly.
EPS Next Y17.87%
EPS Next 2Y21.65%
EPS Next 3Y21.52%
EPS Next 5YN/A
Revenue Next Year14.89%
Revenue Next 2Y15.92%
Revenue Next 3Y14.9%
Revenue Next 5Y19.39%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 44.52 indicates a quite expensive valuation of NTNX.
63.44% of the companies in the same industry are more expensive than NTNX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of NTNX to the average of the S&P500 Index (27.55), we can say NTNX is valued expensively.
With a Price/Forward Earnings ratio of 33.09, NTNX can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, NTNX is valued a bit cheaper than the industry average as 64.87% of the companies are valued more expensively.
NTNX is valuated rather expensively when we compare the Price/Forward Earnings ratio to 24.00, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 44.52
Fwd PE 33.09

4.2 Price Multiples

NTNX's Enterprise Value to EBITDA is on the same level as the industry average.
NTNX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. NTNX is cheaper than 78.14% of the companies in the same industry.
Industry RankSector Rank
P/FCF 27.64
EV/EBITDA 140.79

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
NTNX's earnings are expected to grow with 21.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.49
PEG (5Y)N/A
EPS Next 2Y21.65%
EPS Next 3Y21.52%

0

5. Dividend

5.1 Amount

NTNX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NUTANIX INC - A

NASDAQ:NTNX (12/26/2024, 7:36:59 PM)

After market: 63.6 -0.07 (-0.11%)

63.67

-0.78 (-1.21%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-26 2024-11-26/amc
Earnings (Next)N/A N/A
Inst Owners80.17%
Inst Owner Change9.53%
Ins Owners0.4%
Ins Owner Change5.04%
Market Cap17.06B
Analysts81.67
Price Target81.82 (28.51%)
Short Float %3.03%
Short Ratio2.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)32.34%
Min EPS beat(2)32.02%
Max EPS beat(2)32.66%
EPS beat(4)4
Avg EPS beat(4)46.26%
Min EPS beat(4)32.02%
Max EPS beat(4)66.3%
EPS beat(8)8
Avg EPS beat(8)55.11%
EPS beat(12)12
Avg EPS beat(12)65.27%
EPS beat(16)16
Avg EPS beat(16)56.39%
Revenue beat(2)2
Avg Revenue beat(2)0.69%
Min Revenue beat(2)0.05%
Max Revenue beat(2)1.33%
Revenue beat(4)3
Avg Revenue beat(4)0.38%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)1.33%
Revenue beat(8)6
Avg Revenue beat(8)0.89%
Revenue beat(12)8
Avg Revenue beat(12)1.35%
Revenue beat(16)12
Avg Revenue beat(16)1.73%
PT rev (1m)10.52%
PT rev (3m)11.76%
EPS NQ rev (1m)3.44%
EPS NQ rev (3m)3.44%
EPS NY rev (1m)4.59%
EPS NY rev (3m)4.11%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.01%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 44.52
Fwd PE 33.09
P/S 7.65
P/FCF 27.64
P/OCF 24.75
P/B N/A
P/tB N/A
EV/EBITDA 140.79
EPS(TTM)1.43
EY2.25%
EPS(NY)1.92
Fwd EY3.02%
FCF(TTM)2.3
FCFY3.62%
OCF(TTM)2.57
OCFY4.04%
SpS8.32
BVpS-2.56
TBVpS-3.27
PEG (NY)2.49
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.62%
ROE N/A
ROCE 4.52%
ROIC 3.57%
ROICexc N/A
ROICexgc N/A
OM 1.95%
PM (TTM) N/A
GM 85.43%
FCFM 27.69%
ROA(3y)-16.56%
ROA(5y)-28.9%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.42%
GM growth 5Y2.41%
F-Score7
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 0.94
Debt/EBITDA 4.94
Cap/Depr 98.46%
Cap/Sales 3.23%
Interest Coverage 250
Cash Conversion 591.16%
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 1.25
Altman-Z 1.77
F-Score7
WACC11.8%
ROIC/WACC0.3
Cap/Depr(3y)81.4%
Cap/Depr(5y)80.34%
Cap/Sales(3y)3.37%
Cap/Sales(5y)4.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.83%
EPS Next Y17.87%
EPS Next 2Y21.65%
EPS Next 3Y21.52%
EPS Next 5YN/A
Revenue 1Y (TTM)14.86%
Revenue growth 3Y15.51%
Revenue growth 5Y11.69%
Sales Q2Q%15.63%
Revenue Next Year14.89%
Revenue Next 2Y15.92%
Revenue Next 3Y14.9%
Revenue Next 5Y19.39%
EBIT growth 1Y137.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year49.18%
EBIT Next 3Y35.43%
EBIT Next 5YN/A
FCF growth 1Y833.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y446.56%
OCF growth 3YN/A
OCF growth 5Y73.99%